DSM-Firmenich AG (FRA:ZX6) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZX6 DSM-Firmenich AG FRA:ZX6
60 GF Score
Price €84.56
GF Value €76.29
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is DSM-Firmenich AG Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:ZX6
60GF Score
DSM-Firmenich AG FRA:ZX6
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DSM-Firmenich AG (FRA:ZX6) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of €84.56 is trading 10.8% above its estimated GF Value™ of €76.29. GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.

Key valuation signals for FRA:ZX6:

  • Dividends Received:
  • GF Value™: €76.29 vs. price of €84.56 (10.8% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the FRA:ZX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
60GF Score

Get the complete analysis for FRA:ZX6

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€84.56
Price
€76.29
GF Value